The transaction is valued at approximately USD 11m based on a purchase price of USD 0.125 for each outstanding common share of IEBS, and includes the redemption of USD 8.425 m of Independence's convertible preferred stock at the redemption price of USD 1,000 per share.
This acquisition is expected to close early in 1Q18, subject to standard regulatory approvals, shareholder approvals from IEBS, as well as other customary conditions.
As per the agreement, Independence shareholders will receive merger consideration in cash, for each share of IEBS. The transaction is currently valued at nearly USD11.0m based on a purchase price of USD0.125 for each outstanding common share of IEBS and includes the redemption of USD8.425m of Independence's convertible preferred stock at the redemption price of USD1,000 per share.
Subject to regulatory approvals, shareholder approvals from IEBS, as well as other customary conditions, the transaction is expected to close early in the first quarter of 2018.
Now a monitoring inspection by Ofsted inspectors reveals that the school on Blaydon Bank is making good progress since the IEB was appointed.
In September, a shadow governing body will be appointed made up of representatives from the local authority, parents, staff and the community to work alongside the IEB.
After six months, the IEB will be dissolved and the shadow governing body will take over full responsibility for the school.
Since then, under the guidance of the head teacher and the IEB, standards are starting to improve.
Utilization of IEBs provides several important benefits for cancer CP.
IEBs may be subdivided into several categories representing a wide spectrum of biological processes, as shown in Table 4.
IGF-1 underscores the successful use of IEBs in guiding CP agent development.
IEBs play a critical role in the design and analysis of phase 1 and 2 clinical trials of CP agents in cohorts of patients with preinvasive neoplasia.